AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2023

Dec 19, 2023

Director's Dealing

Opens in your device viewer

Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2023-12-15

Reporting Person: Puhlmann Markus (Chief Medical Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-15	Common Stock	P	135006	$0.2687	Acquired	635006	Direct
2023-12-18	Common Stock	P	60419	$0.2559	Acquired	695425	Direct
2023-12-19	Common Stock	P	400000	$0.3425	Acquired	1095425	Direct